tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Iovance Biotherapeutics Inc

IOVA
Add to Watchlist
4.070USD
-0.620-13.22%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.82BMarket Cap
LossP/E TTM

Iovance Biotherapeutics Inc

4.070
-0.620-13.22%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

IOVA Financials

See Iovance Biotherapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Iovance Biotherapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.13
Revenue / Forecast
--/87.67M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
263.50M
60.60%
EPS(YoY)
-1.09
14.78%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
47.50%-0.19
31.49%-0.18
9.00%-0.25
2.09%-0.33
15.22%-0.36
43.30%-0.26
40.47%-0.28
28.16%-0.34
15.54%-0.42
28.90%-0.45
---0.46
---0.47
---0.50
---0.64
----
----
----
----
----
----
Revenue
44.82%71.43M
17.74%86.77M
15.20%67.45M
92.73%59.95M
6798.46%49.32M
15189.21%73.69M
12385.07%58.55M
12969.75%31.11M
--715.00K
--482.00K
--469.00K
--238.00K
----
----
----
----
----
----
----
----
Net Profit
31.95%-79.05M
8.47%-71.90M
-9.23%-91.25M
-14.99%-111.66M
-2.82%-116.16M
32.50%-78.56M
26.56%-83.54M
8.85%-97.10M
-5.22%-112.98M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
-45.23%-99.33M
-47.04%-86.12M
-29.09%-81.35M
Net Margin
53.01%-110.66%
22.27%-82.87%
5.18%-135.28%
40.34%-186.25%
98.51%-235.51%
99.56%-106.60%
99.41%-142.67%
99.30%-312.16%
---15800.84%
---24145.02%
---24255.86%
---44759.66%
----
----
----
----
----
----
----
----
Gross Margin
3476.94%28.55%
3.01%39.35%
-7.45%29.61%
751.14%5.48%
99.91%-0.85%
104.74%38.20%
103.88%31.99%
99.89%-0.84%
---915.52%
---805.60%
---825.37%
---761.34%
----
----
----
----
----
----
----
----
Debt to assets ratio
4.44%0.11%
-0.30%0.11%
9.51%0.11%
6.27%0.11%
-10.02%0.10%
-14.29%0.11%
-14.00%0.10%
-21.47%0.10%
-5.19%0.11%
-14.91%0.13%
--0.12%
--0.13%
--0.12%
--0.15%
----
----
----
----
----
----
Income Statement
Revenue
44.82%71.43M
17.74%86.77M
15.20%67.45M
92.73%59.95M
6798.46%49.32M
15189.21%73.69M
12385.07%58.55M
12969.75%31.11M
--715.00K
--482.00K
--469.00K
--238.00K
----
----
----
----
----
----
----
----
Operating profit
33.14%-81.04M
7.22%-73.46M
-0.78%-89.76M
-11.64%-113.77M
-2.97%-121.22M
34.70%-79.18M
24.75%-89.07M
7.42%-101.91M
-6.19%-117.72M
-13.29%-121.26M
-17.90%-118.36M
-10.38%-110.09M
-20.87%-110.86M
-7.61%-107.04M
-16.41%-100.39M
-22.48%-99.73M
-21.36%-91.71M
-45.85%-99.47M
-46.26%-86.24M
-27.97%-81.43M
Net Profit
31.95%-79.05M
8.47%-71.90M
-9.23%-91.25M
-14.99%-111.66M
-2.82%-116.16M
32.50%-78.56M
26.56%-83.54M
8.85%-97.10M
-5.22%-112.98M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
-45.23%-99.33M
-47.04%-86.12M
-29.09%-81.35M
Balance Sheet
Current assets
-9.00%466.50M
-3.14%442.69M
-13.94%429.09M
-12.39%422.50M
32.97%512.65M
48.46%457.02M
30.32%498.58M
75.44%482.26M
-39.55%385.53M
-35.75%307.85M
3.43%382.59M
-36.31%274.88M
30.17%637.78M
-5.68%479.12M
-36.56%369.88M
-35.26%431.59M
-19.04%489.97M
-20.15%507.96M
-19.43%583.03M
-14.82%666.64M
Total current liabilities
5.48%129.42M
13.09%138.36M
6.55%125.78M
37.93%129.16M
47.44%122.69M
10.91%122.34M
29.80%118.06M
5.64%93.64M
-4.65%83.21M
20.57%110.31M
14.78%90.95M
38.09%88.64M
13.23%87.27M
2.56%91.48M
22.36%79.25M
6.04%64.19M
39.99%77.08M
62.56%89.20M
0.58%64.77M
10.25%60.53M
Total assets
-4.25%925.66M
0.30%913.17M
-8.69%904.95M
-5.90%907.44M
11.14%966.74M
16.67%910.43M
16.29%991.12M
27.34%964.32M
5.46%869.83M
17.53%780.35M
56.12%852.32M
23.97%757.29M
17.61%824.77M
-14.58%663.98M
-34.13%545.92M
-28.37%610.88M
-6.57%701.25M
1.15%777.33M
5.95%828.83M
4.31%852.79M
Total liabilities
2.53%203.91M
7.28%214.59M
-6.89%202.66M
6.73%208.95M
4.78%198.88M
2.19%200.02M
22.07%217.66M
9.54%195.78M
20.22%189.81M
19.10%195.74M
17.16%178.31M
29.33%178.72M
5.78%157.89M
5.57%164.34M
16.62%152.19M
27.51%138.19M
44.71%149.26M
39.04%155.67M
85.22%130.50M
82.89%108.38M
Total equity
-6.01%721.75M
-1.66%698.58M
-9.20%702.29M
-9.11%698.49M
12.92%767.87M
21.52%710.40M
14.75%773.46M
32.83%768.54M
1.97%680.02M
17.01%584.61M
71.18%674.01M
22.40%578.57M
20.81%666.88M
-19.63%499.64M
-43.62%393.74M
-36.50%472.69M
-14.74%551.99M
-5.31%621.66M
-1.90%698.33M
-1.83%744.41M
Cash Flow Statement
Net operating income
30.49%-72.07M
28.28%-52.56M
-33.45%-78.70M
31.48%-67.45M
15.20%-103.69M
12.71%-73.30M
29.86%-58.97M
-4.77%-98.43M
-22.51%-122.28M
-8.11%-83.97M
-32.10%-84.08M
-21.02%-93.95M
-35.25%-99.81M
-44.24%-77.67M
-10.32%-63.65M
-43.75%-77.64M
-18.29%-73.80M
14.11%-53.85M
-42.40%-57.69M
-47.42%-54.01M
Net investment
-28.19%11.39M
-96.73%775.00K
134.86%17.01M
-65.58%13.84M
114.23%15.87M
132.50%23.68M
38.24%-48.80M
125.65%40.22M
-172.69%-111.51M
-15901.52%-72.84M
-207.19%-79.01M
-263.72%-156.78M
77.30%153.40M
-99.34%461.00K
478.25%73.72M
160.17%95.76M
12.05%86.52M
18.02%69.34M
124.07%12.75M
62.44%-159.16M
Net financing
-34.18%94.33M
2332.74%56.17M
109.89%88.06M
-91.34%13.23M
-25.96%143.31M
140.02%2.31M
-79.31%41.95M
14809.76%152.82M
-25.02%193.58M
-99.50%962.00K
90033.33%202.80M
149.59%1.02M
18119.62%258.17M
4492.17%190.57M
-98.92%225.00K
-101.26%-2.07M
-97.19%1.42M
40.30%4.15M
1681.48%20.77M
-71.15%163.98M

FAQs

What is the total revenue of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total revenue reached 263.50M, with a year-on-year change of 164.07M.

What are the current assets of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its current assets were 442.69M, with a year-on-year change of -3.14.

What are the total assets of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total assets of Iovance Biotherapeutics Inc were 913.17M, with a year-on-year change of 0.30.

What are the total liabilities of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total liabilities of Iovance Biotherapeutics Inc were 214.59M, with a year-on-year change of 7.28.

What is the total equity of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its total equity of Iovance Biotherapeutics Inc was 698.58M, with a year-on-year change of -1.66.

What is the net operating income of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net operating income of Iovance Biotherapeutics Inc was -398.21M, with a year-on-year change of -2.66.

What is the net investment of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net investment of Iovance Biotherapeutics Inc was 47.50M, with a year-on-year change of 149.26.

What is the net financing of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net financing of Iovance Biotherapeutics Inc was 300.77M, with a year-on-year change of -23.01.

What is the Earnings Per Share (EPS) of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.09, with a year-on-year change of 14.78.

What is the net income of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net income was -390.98M, with a year-on-year change of -5.05.

What is the net margin of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its net profit margin was -148.38, with a year-on-year change of 34.59.

What is the gross margin of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its gross margin was 20.64, with a year-on-year change of -15.51.

What is the debt-to-asset ratio of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.11, with a year-on-year change of -0.30.

What is the Return on Equity (ROE) of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -55.50, with a year-on-year change of 3.45.

What is the Return on Assets (ROA) of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.88, with a year-on-year change of 2.60.

What is the operating profit of Iovance Biotherapeutics Inc?

According to Iovance Biotherapeutics Inc's FY2025 earnings report, its operating profit was -398.21M, with a year-on-year change of -2.66.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy